HIGHLIGHTS
- who: Pei-Wei Shueng and collaborators from the Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan have published the research: Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism, in the Journal: (JOURNAL)
- what: This study investigated whether sorafenib resistance could be reversed by suppressing fatty acid synthesis using a fatty acid synthase (FASN) inhibitor in HCC cells. The authors aimed to investigate the roles of FASN and related metabolisms in sorafenib resistance, and to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.